Your browser doesn't support javascript.
loading
Structure-function analysis of the AMPK activator SC4 and identification of a potent pan AMPK activator.
Ovens, Ashley J; Gee, Yi Sing; Ling, Naomi X Y; Yu, Dingyi; Hardee, Justin P; Chung, Jin D; Ngoei, Kevin R W; Waters, Nicholas J; Hoffman, Nolan J; Scott, John W; Loh, Kim; Spengler, Katrin; Heller, Regine; Parker, Michael W; Lynch, Gordon S; Huang, Fei; Galic, Sandra; Kemp, Bruce E; Baell, Jonathan B; Oakhill, Jonathan S; Langendorf, Christopher G.
Affiliation
  • Ovens AJ; Metabolic Signalling Laboratory, St. Vincent's Institute of Medical Research, Fitzroy 3065, Australia.
  • Gee YS; Exercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne 3000, Australia.
  • Ling NXY; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Australia.
  • Yu D; Metabolic Signalling Laboratory, St. Vincent's Institute of Medical Research, Fitzroy 3065, Australia.
  • Hardee JP; Protein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Fitzroy 3065, Australia.
  • Chung JD; Centre for Muscle Research, Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Victoria 3010, Australia.
  • Ngoei KRW; Centre for Muscle Research, Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Victoria 3010, Australia.
  • Waters NJ; Protein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Fitzroy 3065, Australia.
  • Hoffman NJ; Protein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Fitzroy 3065, Australia.
  • Scott JW; Exercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne 3000, Australia.
  • Loh K; Protein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Fitzroy 3065, Australia.
  • Spengler K; The Florey Institute of Neuroscience and Mental Health, Royal Parade, Parkville 3052, Australia.
  • Heller R; Protein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Fitzroy 3065, Australia.
  • Parker MW; Institute of Molecular Cell Biology, Center for Molecular Biomedicine, Jena University Hospital, 07745 Jena, Germany.
  • Lynch GS; Institute of Molecular Cell Biology, Center for Molecular Biomedicine, Jena University Hospital, 07745 Jena, Germany.
  • Huang F; ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy 3065, Australia.
  • Galic S; Structural Biology and Computational Design Laboratory, Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
  • Kemp BE; Centre for Muscle Research, Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Victoria 3010, Australia.
  • Baell JB; School of Pharmaceutical Sciences, Nanjing Tech University, No. 30 South Puzhu Road, Nanjing 211816, People's Republic of China.
  • Oakhill JS; Protein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Fitzroy 3065, Australia.
  • Langendorf CG; Exercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne 3000, Australia.
Biochem J ; 479(11): 1181-1204, 2022 06 17.
Article in En | MEDLINE | ID: mdl-35552369
ABSTRACT
The AMP-activated protein kinase (AMPK) αßγ heterotrimer is a primary cellular energy sensor and central regulator of energy homeostasis. Activating skeletal muscle AMPK with small molecule drugs improves glucose uptake and provides an opportunity for new strategies to treat type 2 diabetes and insulin resistance, with recent genetic and pharmacological studies indicating the α2ß2γ1 isoform combination as the heterotrimer complex primarily responsible. With the goal of developing α2ß2-specific activators, here we perform structure/function analysis of the 2-hydroxybiphenyl group of SC4, an activator with tendency for α2-selectivity that is also capable of potently activating ß2 complexes. Substitution of the LHS 2-hydroxyphenyl group with polar-substituted cyclohexene-based probes resulted in two AMPK agonists, MSG010 and MSG011, which did not display α2-selectivity when screened against a panel of AMPK complexes. By radiolabel kinase assay, MSG010 and MSG011 activated α2ß2γ1 AMPK with one order of magnitude greater potency than the pan AMPK activator MK-8722. A crystal structure of MSG011 complexed to AMPK α2ß1γ1 revealed a similar binding mode to SC4 and the potential importance of an interaction between the SC4 2-hydroxyl group and α2-Lys31 for directing α2-selectivity. MSG011 induced robust AMPK signalling in mouse primary hepatocytes and commonly used cell lines, and in most cases this occurred in the absence of changes in phosphorylation of the kinase activation loop residue α-Thr172, a classical marker of AMP-induced AMPK activity. These findings will guide future design of α2ß2-selective AMPK activators, that we hypothesise may avoid off-target complications associated with indiscriminate activation of AMPK throughout the body.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / AMP-Activated Protein Kinases Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals Language: En Journal: Biochem J Year: 2022 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / AMP-Activated Protein Kinases Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals Language: En Journal: Biochem J Year: 2022 Document type: Article Affiliation country: Australia